Activin‐A Regulates Bone Morphogenetic Protein Signaling in Pulmonary Endothelial Cells Without Affecting Bone Morphogenetic Protein Type‐II Receptor Expression

ABSTRACT Activin‐A is elevated in pulmonary arterial hypertension (PAH) patients, and reportedly suppresses BMPR‐II. This suggests one mechanism of action for PAH drug, sotatercept, an activin‐ligand trap. However, we were unable to confirm that activin‐A reduces BMPR‐II in pulmonary endothelial cel...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Benjamin J. Dunmore, Nobuhiro Kikuchi, Wei Li, Paul D. Upton, Nicholas W. Morrell
Formáid: Alt
Teanga:Béarla
Foilsithe / Cruthaithe: Wiley 2025-04-01
Sraith:Pulmonary Circulation
Rochtain ar líne:https://doi.org/10.1002/pul2.70095
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!